TGF-β induced myofibroblasts are also found in glaucoma (Park et al., 2013), age-related macular degeneration (AMD; Seregard et al., 1994), and cataract (Novotny and Pau, 1984), therefore there is a high value for targeted therapeutics against TGF-β induced myofibroblasts. The gene discussed is TGFB1; the disease is glaucoma.